Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04684537
Other study ID # 20200715R
Secondary ID 2021SKHADR033
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2021
Est. completion date December 31, 2022

Study information

Verified date July 2023
Source Shin Kong Wu Ho-Su Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators aim to compare the effect of extracorporeal shockwave therapy with ultrasound-guided piriformis coticosteroid injection in treatment of PS.


Description:

Piriformis syndrome (PS) is one of the common etiology of low back pain. The cause of PS is due to myofascial syndrome of piriformis muscle, leading to piriformis muscle spasm, string-like taut band, and trigger point. Consequently, it may compresses the sciatic nerve which arise from sciatic notch and passes under the piriformis muscle. Conservative treatment of PS includes therapeutic exercise, diathermy, and local steroid injection. Among them, as radiology techniques advance, ultrasound-guided piriformis injection becomes popular for diagnosis block and treatment. Nowadays, extracorporeal shockwave therapy has widely applied in musculoskeletal disease such as plantar fasciitis, tennis elbow, and calcific tendinitis of the shoulder. However, to the investigators best knowledge, there is no study comparing the therapeutic effect between local steroid injection and shockwave. In this study, the investigators aim to compare the effect of extracorporeal shockwave therapy with ultrasound-guided piriformis corticosteroid injection. This is a randomized controlled trial. 70 participants will be randomly divided into shockwave group and injection group. The participant in the shockwave group will receive one time extracorporeal shockwave therapy, and injection group will receive one time ultrasound-guided piriformis muscle corticosteroid injection. After the intervention, participant in both groups will receive home-based stretch exercise. Evaluation will be performed at baseline, 1 week, and 5 weeks after intervention. Outcome measures include the pain visual analog scale (VAS), hip range of motion, change of pressure pain threshold, and Oswestry Disability Index (ODI).


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: 1. Age from 20 to 80 2. Unilateral buttock involvement without leg pain or paresthesia 3. Duration of symptoms =1 month 4. Positive trigger point or taut band at piriformis muscle, confirmed by palpation and ultrasound examination 5. Positive FAIR (flexion, adduction, internal rotation) test 6. Positive piriformis resistive test (patient actively abducts and/or externally rotates the hip while the examiner resists these movements Exclusion Criteria: 1. Having received hip, pelvis, or lumbar spine surgery 2. Low back pain or buttock pain due to lumbosacral spine, hip or pelvis lesion other than piriformis syndrome 3. Having received shock wave therapy or corticosteroid injection for buttock pain within the past one month 4. Neurologic deficit in in the lower limbs 5. History of drug allergy to local anesthetics or corticosteroids 6. Pregnancy

Study Design


Intervention

Procedure:
Extracorporeal shockwave therapy (ESWT)
The therapy will be performed with the focused piezoelectric shockwave (F10G4 Richard Wolf GmbH, Germany). The patient will be kept in the hip flexion, adduction and internal rotation position. After sonography-guided localization of the affected muscle and identification of the trigger point by the participant, ultrasound gel is applied to the skin and the applicator couple is placed with an impulse energy flux density of 0.456-0.882 mJ/mm2 for 3500 impulses.
Ultrasound-guided piriformis steroid injection
all the participants will receive ultrasound-guided piriformis injection with 10 mg triamcinolone and 1 c.c. 1% lidocaine for one time.

Locations

Country Name City State
Taiwan Shin Kong Wu Ho-Su Memorial Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Shin Kong Wu Ho-Su Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient's self evaluation At 1-week and 5-week evaluations, patients are asked to report treatment effect by themselves as the following five grades: 5. Complete relief of symptoms; 4. Much improved, no need for further treatment; 3. Mildly improved, need further treatment; 2.No improvement; 1. Worse. change between baseline and at 1 week, 5 weeks after the beginning of the treatment.
Primary The pain visual analog scale (VAS) It measures severity of pain. It is performed with a 100-mm horizontal line. The end of the left side is defined as no pain, and the end of the right side as the worst pain. Participants are requested to report the severity of buttock pain in recent one week. change between baseline and at 1 week, 5 weeks after the beginning of the treatment.
Primary Oswestry Disability Index (ODI) ODI score is used for disability evaluation. It is a self-reported questionnaire with range 0-100. It has 10 questions with an minimal clinical important difference (MCID) of 10 points, with higher scores indicating more disability. The questions include pain intensity, sleep quality, and ability to perform personal care, work, sit, walk, lift, stand, and travel. change between baseline and at 1 week, 5 weeks after the beginning of the treatment.
Secondary hip range of motion Internal and external rotation of the hip on the affected side will be measured with a goniometer by the study assistant. The measurement will be performed in the supine position according the standard procedure. change between baseline and at 1 week, 5 weeks after the beginning of the treatment.
Secondary change of pressure pain threshold It is defined as the amount of pressure needed to shift local sensation from pressure to pain. This is measured with a digital algometer and has been shown to have excellent intrarater reliability in the gluteal region (ICC = .90), with a minimal detectable change of 3.1 N/cm2. The digital algometer, made up of a 1-cm-wide disk, will be placed at the tender point between the ischial tuberosity and the greater trochanter while the patient is lying prone. The algometer's pressure will be increased gradually (with a speed approximately 1 N/cm2 per second) until the participant reports pain. The average value of three repeated measurements is recorded. change between baseline and at 1 week, 5 weeks after the beginning of the treatment.
See also
  Status Clinical Trial Phase
Completed NCT04387877 - Graston Technique in Deep Gluteal Syndrome N/A
Recruiting NCT06130618 - The Effects of Ultrasound Guided Ozone and Lidocaine Injections in Piriformis Syndrome N/A
Completed NCT05680402 - Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome N/A
Active, not recruiting NCT06437795 - Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome N/A
Completed NCT04603703 - Sacroiliac Joint Manipulation Effect in Chronic Piriformis Syndrome. N/A
Completed NCT01752179 - Kinesio Taping Technique and Trigger Point N/A
Completed NCT06435169 - Comparative Presence of Piriformis Syndrome in Patients With Lumbar Disc Bulging and Protrusion
Completed NCT05848063 - Effects of Global Hip Versus Isolated Abductors Strengthening Exercises in Patients Withsecondary Piriformis Syndrome N/A
Completed NCT05271071 - The Importance of Gluteus Maximus Muscle in Patients With Preliminary Diagnosis of Piriformis Syndrome N/A
Completed NCT04842656 - Soft Tissue Techniques in Piriformis Syndrome N/A
Not yet recruiting NCT05404607 - Effects of Fascial Distortion Model With and Without Neuromuscular Inhibition in Patients With Piriformis Syndrome N/A
Recruiting NCT06437327 - Comparison of Effectiveness Between Active Release Technique and Hold Relax Technique in Patients With Piriformis Syndrome N/A
Not yet recruiting NCT05882799 - Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome N/A
Recruiting NCT06102733 - Chronic Pelvic Pain in Females and Males
Not yet recruiting NCT05392933 - Investigation of the Presence of Piriformis Syndrome Accompanying Lumbar Radiculopathy N/A
Completed NCT04588779 - Graston vs Manual Myofascial Release Technique in Piriformis Syndrome. N/A
Recruiting NCT06406023 - Effectiveness of Instrument Assisted Soft Tissue Mobilization in Management of Piriformis Syndrome N/A
Completed NCT05742633 - Comparative Effect of Active Release Technique Versus Self-myofascial Release in Improving Piriformis Syndrome N/A
Completed NCT05370378 - Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Clinical Outcomes in Piriformis Syndrome N/A
Recruiting NCT05915858 - Muscle Energy Technique and Stretching Exercise in Working Pregnant Women With Piriformis Syndrome N/A